Key result
Anthropometric obesity measures, such as BMI, were significantly associated with an increased risk of deep venous thrombosis (HR 1.4 per 1 SD increase) and pulmonary embolism among women, but not men.
Why the study?
Whether sex-specific differences exist for noncancer-related pulmonary embolism and deep venous thrombosis risk factors in middle-aged and older individuals without cardiovascular history has been sparsely studied.
Are anthropometric obesity measures differentially associated with the risk of DVT and PE in women compared to men?
Cohort (n=25,803)
No
Are anthropometric obesity measures differentially associated with the risk of DVT and PE in women compared to men?
Hazard Ratio: 1.4 (95% CI 1.3–1.5)
p-value: p=<0.001
Anthropometric obesity measures are stronger risk factors for DVT and PE in women than in men, particularly among those without prior cardiovascular disease or cancer.
Obesity measures may inform sex-specific VTE risk assessment in women; leaves open causal confirmation and mechanisms.
Background Whether sex-specific differences exist for risk factors for pulmonary embolism (PE) and deep venous thrombosis (DVT), with the exception of pregnancy and estrogen therapy, has been sparsely studied. We aimed to study whether sex-specific differences of risk factors exist for noncancer-related DVT and PE in middle-aged and older individuals without cardiovascular history or previous diagnosis in a population-based historical (retrospective) cohort. Methods and Results Potential venous thromboembolism (VTE) risk factors were registered at baseline in 15 807 women and 9996 men aged 44 to 74 years, who participated in the Malmö Diet and Cancer study (1991-1996). We excluded subjects with a previous history of VTE, cancer, a diagnosis of cardiovascular disease, or a diagnosis of cancer-associated VTE during follow-up. Patients were followed up from baseline until the first event of PE or DVT, death, or December 31, 2018. During the follow-up period, 365 (2.3%) women and 168 (1.7%) men were affected by first DVT, and 309 (2.0%) women and 154 (1.5%) men were affected by first PE. In the multivariable Cox regression models, the anthropometric obesity markers of weight, body mass index, waist and hip circumference, fat percentage, and muscle weight were in a dose-dependent way associated with DVT and PE among women but not men. In an analysis that included patients with cardiovascular disease and cancer-related VTE, the results were similar for women. For men, several obesity measures became significantly associated with PE or DVT but were weaker than in women, especially for DVT. Conclusions Anthropometric obesity measures are more important risk factors for both DVT and PE among women than men, especially for individuals without cardiovascular history or previous diagnosis or cancer-related VTE.
No takes yet. Share an insight, caveat, or question.
Brink et al. (2023) conducted a cohort in Deep venous thrombosis and pulmonary embolism (n=25,803). Anthropometric obesity measures (e.g., body mass index) vs. Lower anthropometric measures (1 SD decrease) was evaluated on First event of deep venous thrombosis (DVT) per 1 SD increase in BMI among women (HR 1.4, 95% CI 1.3-1.5, p=<0.001). Anthropometric obesity measures, such as BMI, were significantly associated with an increased risk of deep venous thrombosis (HR 1.4 per 1 SD increase) and pulmonary embolism among women, but not men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: